Please assess the completion status of the following clinical trial:

Trial Title: Neuromuscular Plasticity in Response to Obesity: Effects of Mechanical Overload, Metabolic Disorders and Age

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 6.0

Eligibility Criteria:
Inclusion Criteria:~* Female or male subject, aged between 20 and 70 years old (inclusive terminals).~* Subject with a BMI greater than 30kg/m².~* Subject with a stable weight for at least 3 months before the start of the study.~* Subject capable and willing to comply with the protocol and willing to give informed consent in writing.~* Subject affiliated to a social security system.~Exclusion Criteria:~Subject with a medical or surgical history deemed by the investigator to be incompatible with the study.~* Subject with a medical contraindication to intense activity.~* Subject weighing more than 170kg, which may damage the dynamometer chair.~* Subject with a treatment that, in the investigator's opinion, may interfere with the evaluation of study criteria, period of exclusion from a previous clinical study.~* Subject who has received a total amount of compensation since the beginning of the calendar year, greater than 4500 euros (amount may change depending on the regulation).~* Subject with a linguistic or physiological disability to sign informed consent.~* Subject deprived of liberty by administrative of juridical decision, under guardianship or curatorship.~* Pregnant or breastfeeding women.

- Gender: ALL
- Minimum Age: 20 Years
- Maximum Age: 70 Years
- Healthy Volunteers: f

Study Arms:
- YOMH (Type: EXPERIMENTAL): Young obese metabolically healthy Description: Aged from 20 to 40 years old and with a glycemia \< 1g/l and a triglyceridemia \< 1,5g/l.
- YOMD (Type: EXPERIMENTAL): Young obese with metabolic disorders~Description: Aged from 20 to 40 years old and with a glycemia \> 1g/l and a triglyceridemia \> 1,5g/l.
- MAOMH (Type: EXPERIMENTAL): Middle-Age obese metabolically healthy~Description: Aged from 40 to 50 years old and with a glycemia \< 1g/l and a triglyceridemia \< 1,5g/l.
- MAOMD (Type: EXPERIMENTAL): Middle-Age obese with metabolic disorders Description: Aged from 40 to 50 years old and with a glycemia \> 1g/l and a triglyceridemia \> 1,5g/l.
- EOMH (Type: EXPERIMENTAL): Elderly obese metabolically healthy~Description: Aged from 50 to 70 years old and with a glycemia \< 1g/l and a triglyceridemia \< 1,5g/l.
- EOMD (Type: EXPERIMENTAL): Elderly obese with metabolic disorders~Description: Aged from 50 to 70 years old and with a glycemia \> 1g/l and a triglyceridemia \> 1,5g/l.

Based on this trial design, predict the completion outcome and termination type (if applicable).